We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Drugmakers increased the list prices of their drugs far beyond the inflation rate between 2017 and the first quarter of 2019, California found in a first-of-its kind study of 1,020 drugs based on the state’s mandatory wholesale price reporting requirements. Read More
Two FDA advisory committees voted 16-8 on Thursday against recommending pediatric labeling for Endo Pharma’s Opana IR (immediate-release oxymorphone). Read More
Gottlieb is “an ideal partner” in the company’s “work to help define RWE's role in the development, delivery, and payment of treatments,” said Aetion CEO Carolyn Magill. Read More
Combining the drug portfolios of the merging companies “may give them increased negotiating leverage to force buyers to provide them with more favorable terms across multiple product categories,” the senators said. Read More